Practice of pharmacy; requiring licensure of certain out-of-state pharmacies; requiring certain inspections; providing administrative remedies and penalties. Effective date.
SB1033 creates a new licensing and inspection framework for out-of-state pharmacies that ship drugs into Oklahoma. Under the bill, these pharmacies must be licensed by the Oklahoma State Board of Pharmacy and comply with Oklahoma pharmacy laws and Board rules, including requirements related to technician-to-pharmacist ratios, drug storage and delivery practices, and other violations the Board may identify. The bill also specifically treats shipment of drugs intended to induce an abortion in violation of state law as a disciplinary violation.
The bill requires the Board to conduct an initial on-site inspection of covered out-of-state pharmacies within six months of the bill’s effective date for existing operations, or as soon as practicable for new operations, followed by annual inspections. If violations are found, the Board must notify the pharmacist in charge, order correction, and impose fines of up to $50,000 per violation. A follow-up inspection must occur within 90 days, and if violations are not corrected, the pharmacy license and pharmacist in charge’s license must be permanently revoked. The bill also requires inspections to be performed directly by Board inspectors and paid for by the pharmacy, rather than relying solely on inspections from other states.
The bill would expand Oklahoma’s regulatory reach over mail-order and other nonresident pharmacies serving Oklahoma patients, adding new licensing, inspection, and enforcement obligations. It would also create a specific statutory basis for discipline tied to abortion-related drug shipments, which could affect pharmacies that dispense medications across state lines. The measure is set to become effective November 1, 2025.
Overall sentiment in the available record appears limited but generally procedural, as the bill had been referred to the Senate Health and Human Services committee and no votes or committee debate were provided. Because there are no transcripts or recorded votes in the materials, there is no direct evidence of support or opposition from lawmakers in the available context.
The main points of contention likely concern the bill’s abortion-related enforcement provision, the requirement for Oklahoma inspections of out-of-state pharmacies, and the size of the penalties and license revocation consequences. Pharmacies operating outside Oklahoma may view the bill as burdensome or duplicative, while supporters would likely frame it as a patient-safety and state-enforcement measure ensuring compliance with Oklahoma law.
SB1033 would add a new section to Title 59 of the Oklahoma Statutes governing out-of-state pharmacies that ship drugs into Oklahoma. It would require licensure by the State Board of Pharmacy, authorize Board inspections and disciplinary action, and establish fines and license revocation for specified violations. The bill would also impose direct inspection costs on the pharmacies and limit reliance on inspections by other states, thereby expanding Oklahoma’s oversight of nonresident pharmacy operations.
The available legislative record shows no committee transcript or vote history, so there is no documented floor or committee sentiment to assess. Based on the bill’s referral status and text alone, the measure appears to be a regulatory and enforcement proposal rather than one with recorded bipartisan or partisan debate in the provided materials.
The most notable contention points are likely the bill’s abortion-related prohibition, which could draw legal and political opposition, and the requirement that out-of-state pharmacies submit to Oklahoma licensing and annual on-site inspections. The bill’s strong penalties—up to $50,000 per violation and permanent revocation for failure to correct violations—may also be disputed as overly punitive, especially by mail-order pharmacies and interstate pharmacy operators. Supporters would likely emphasize consumer protection, drug safety, and state enforcement authority.